Select Sector SPDR Trust · net assets $40.6B · 65 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.7% · STIV: 0.3% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $2.28B | $3.42B | $4.27B |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $2.81B | $3.96B | $4.26B |
| Net realized gain (non-derivative) | $243M | $284M | $327M |
| Net unrealized appreciation (non-derivative) | $-485M | $560M | $2.12B |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly & Co EC | $6.7B | 16.51% |
| Johnson & Johnson EC | $4.32B | 10.64% |
| Abbvie Inc EC | $3.14B | 7.74% |
| Unitedhealth Group Inc EC | $2.67B | 6.57% |
| Merck & Co Inc EC | $2.24B | 5.52% |
| Amgen Inc EC | $1.38B | 3.40% |
| Thermo Fisher Scientific Inc EC | $1.32B | 3.24% |
| Abbott Laboratories EC | $1.12B | 2.75% |
| Gilead Sciences Inc EC | $1.11B | 2.73% |
| Intuitive Surgical Inc EC | $995M | 2.45% |
| Pfizer Inc EC | $970M | 2.39% |
| Cvs Health Corp EC | $932M | 2.30% |
| Vertex Pharmaceuticals Inc EC | $891M | 2.19% |
| Danaher Corp EC | $848M | 2.09% |
| Bristol-myers Squibb Co EC | $831M | 2.05% |
| Stryker Corp EC | $767M | 1.89% |
| Medtronic PLC EC | $710M | 1.75% |
| Mckesson Corp EC | $642M | 1.58% |
| Elevance Health Inc EC | $593M | 1.46% |
| Cigna Group/the EC | $515M | 1.27% |
| Boston Scientific Corp EC | $448M | 1.10% |
| Regeneron Pharmaceuticals Inc EC | $440M | 1.08% |
| Hca Healthcare Inc EC | $428M | 1.05% |
| Cardinal Health Inc EC | $393M | 0.97% |
| Cencora Inc EC | $389M | 0.96% |
| Edwards Lifesciences Corp EC | $368M | 0.91% |
| Humana Inc EC | $337M | 0.83% |
| Becton Dickinson & Co EC | $295M | 0.73% |
| Idexx Laboratories Inc EC | $293M | 0.72% |
| Agilent Technologies Inc EC | $265M | 0.65% |
| Waters Corp EC | $260M | 0.64% |
| Iqvia Holdings Inc EC | $228M | 0.56% |
| Biogen Inc EC | $225M | 0.56% |
| Zoetis Inc EC | $213M | 0.52% |
| Centene Corp EC | $213M | 0.52% |
| Ge Healthcare Technologies Inc EC | $206M | 0.51% |
| Resmed Inc EC | $200M | 0.49% |
| Veeva Systems Inc EC | $188M | 0.46% |
| Dexcom Inc EC | $184M | 0.45% |
| Mettler-toledo International Inc EC | $182M | 0.45% |
| West Pharmaceutical Services Inc EC | $179M | 0.44% |
| Moderna Inc EC | $175M | 0.43% |
| Quest Diagnostics Inc EC | $166M | 0.41% |
| Labcorp Holdings Inc EC | $162M | 0.40% |
| Steris PLC EC | $146M | 0.36% |
| Incyte Corp EC | $134M | 0.33% |
| Viatris Inc EC | $131M | 0.32% |
| Zimmer Biomet Holdings Inc EC | $118M | 0.29% |
| Cooper Cos Inc/the EC | $98.8M | 0.24% |
| State Street Global Advisors STIV | $95.3M | 0.23% |
| Revvity Inc EC | $87.7M | 0.22% |
| Solventum Corp EC | $80.2M | 0.20% |
| Align Technology Inc EC | $79.4M | 0.20% |
| Bio-techne Corp EC | $78.1M | 0.19% |
| Baxter International Inc EC | $77.8M | 0.19% |
| Charles River Laboratories International Inc EC | $77.2M | 0.19% |
| Insulet Corp EC | $74.5M | 0.18% |
| Henry Schein Inc EC | $57.1M | 0.14% |
| Universal Health Services Inc EC | $56M | 0.14% |
| Davita Inc EC | $50.4M | 0.12% |
Showing top 60 of 65 holdings.
Loading...
